Evidence map›Paper›PMID 39349033›Full record

ReviewClinics in geriatric medicine2024

Optimal Blood Pressure Targets with Age.

Mark A Supiano

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in geriatric medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mark A SupianoDivision of Geriatrics, Spencer Fox Eccles School of Medicine, Center on Aging, University of Utah, 30 North Mario Capecchi Drive, 2nd Floor North, Salt Lake City, UT 84112, USA. Electronic address: mark.supiano@utah.edu.

Funding

The SPRINT Alzheimer's, Seniors and Kidney Study (SPRINT ASK)R01AG055606 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI REBOUSSIN, DAVID M, WILLIAMSON, JEFF DOUGLAS · 2017 to 2023
$9.9M
Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimensR01AG065805 · NIA · UNIVERSITY OF UTAH · PI BRESS, ADAM P · 2020 to 2023
$2.7M
NIA NIH HHS R01 AG055606NIA NIH HHS R01 AG065805
6 · The paper itself

Abstract

The focus of antihypertensive therapy in older adults should be on lowering the systolic blood pressure (SBP) to the patient's "optimal" benefit-based target goal. Applying benefit-based therapy to the majority of adults aged 65 years or older who are at high cardiovascular disease or cognitive impairment risk favors an SBP goal of less than 130 mm Hg, and for some, a goal of 120 mm Hg may be considered.

Indexed as

Antihypertensive AgentsBlood PressureHypertensionAgedAge FactorsAgingCardiovascular DiseasesHumansAntihypertensive AgentsAge-friendly careClinical guidelinesCognitive impairmentDementiaPatient-centeredRandomized clinical trialsTherapeutic nihilism

Identifiers

PMID39349033
PMCPMC11443060

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.